XML 25 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation
 9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
On June 8, 2022, the stockholders of Nektar approved an amendment to the Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of Common Stock authorized for issuance thereunder by 5,000,000 shares.
In connection with our Restructuring Plan, we recorded the benefit for the forfeitures of stock awards from employees who were terminated as part of our reduction-in-force during the nine months ended September 30, 2022. We recognized total stock-based compensation expense in our Condensed Consolidated Statements of Operations as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Cost of goods sold
$720 $688 $2,037 $2,131 
Research and development
5,422 14,138 22,215 41,779 
General and administrative
5,369 9,831 18,401 28,359 
Restructuring, impairment and other costs of terminated program1,007 — 1,929 — 
Total stock-based compensation$12,518 $24,657 $44,582 $72,269 
We issued stock-based awards of our common stock as follows (shares in thousands):
Three Months Ended September 30,Nine Months Ended
September 30,
2022202120222021
Options granted
5,890 397 6,019 674 
Weighted-average grant-date fair value of options granted
$3.23 $9.36 $3.24 $9.72 
RSUs granted
3,896 727 4,905 1,614 
Weighted-average grant-date fair value of RSUs granted
$4.73 $16.48 $4.98 $17.98